IN2014MU00071A - - Google Patents

Info

Publication number
IN2014MU00071A
IN2014MU00071A IN71MU2014A IN2014MU00071A IN 2014MU00071 A IN2014MU00071 A IN 2014MU00071A IN 71MU2014 A IN71MU2014 A IN 71MU2014A IN 2014MU00071 A IN2014MU00071 A IN 2014MU00071A
Authority
IN
India
Prior art keywords
hydrate
useful
formula
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
Inventor
Pravin Shinde
Ramprasad Yadav
Arvind Yekanathsa Merwade
Keshav Deo
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN71MU2014 priority Critical patent/IN2014MU00071A/en
Publication of IN2014MU00071A publication Critical patent/IN2014MU00071A/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The present invention relates to a process for preparing dimer of zoledronic acid, a pharmaceutically acceptable salt thereof, or a hydrate thereof, which is useful as reference marker. Formula II
IN71MU2014 2014-01-08 2014-01-08 IN2014MU00071A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN71MU2014 IN2014MU00071A (en) 2014-01-08 2014-01-08

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN71MU2014 IN2014MU00071A (en) 2014-01-08 2014-01-08

Publications (1)

Publication Number Publication Date
IN2014MU00071A true IN2014MU00071A (en) 2015-08-28

Family

ID=54393337

Family Applications (1)

Application Number Title Priority Date Filing Date
IN71MU2014 IN2014MU00071A (en) 2014-01-08 2014-01-08

Country Status (1)

Country Link
IN (1) IN2014MU00071A (en)

Similar Documents

Publication Publication Date Title
NZ726356A (en) Processes for preparing antiviral compounds
PH12016502177A1 (en) Processes of preparing a jak1 inhibitor and new forms thereto
MX2017006266A (en) Heteroaryl compounds as irak inhibitors and uses thereof.
TW201613866A (en) Process for preparing fluorinated iminopyridine compounds
PH12017500833A1 (en) Synthesis of copanlisib and its dihydrochloride salt
TW201613859A (en) Analogs of PRIDOPIDINE, their preparation and use
MX2015005286A (en) Process for preparing bile acid derivatives.
TW201613853A (en) Synthesis of polycyclic-carbamoylpyridone compounds
MX362383B (en) Oxabicyclo [2.2.2] acid gpr120 modulators.
JO3487B1 (en) Synthesis of copanlisib and its dihydrochloride salt
PH12016502229A1 (en) Process for preparing phosphorus-containing cyanohydrins
MX2017008280A (en) Process of making cenicriviroc and related analogs.
BR112017019850A2 (en) Improved process for preparing apremilast
MX2019001228A (en) Production method for pyrazole-amide compound.
MX2016015465A (en) Oral pharmaceutical composition of isotretinoin.
IN2014MU01192A (en)
IN2014MU00195A (en)
BR112017004166A2 (en) cephalosporin derivative salt, crystalline solid form thereof and method for producing the same
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
IN2014MU00194A (en)
IN2014MU01196A (en)
TN2014000135A1 (en) Substituted pyrazole analogues as rar antagonists
IN2014MU00071A (en)
IN2014MU00072A (en)
MX2018001837A (en) An improved process for the preparation of tetrofosmin or acid addition salt thereof.